Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
07 February 2026PASTEUR Act Reintroduced in Congress
The PASTEUR Act (Pioneering Antimicrobial Subscriptions to End Upsurging Resistance) was reintroduced in the U.S. Congress for the fourth time, now sponsored by a bipartisan group of Representatives including Buddy Carter (R-GA), Scott Peters (D-CA), Nick Langworthy (R-NY), Mike Levin (D-CA), and Mike Carey (R-OH). The legislation aims to reform how antimicrobial drugs are developed […]
Read more... -
05 February 2026Ultra-rapid nanoplasmonic colorimetry in microfluidics for antimicrobial susceptibility testing directly from specimens
Researchers developed QolorPhAST, a modular, automated antimicrobial susceptibility testing (AST) platform that uses nanoplasmonic colorimetry and microfluidics to rapidly identify bacteria and determine their antibiotic resistance. The system delivers results within minutes rather than days, eliminating the need for overnight cultures and pathogen isolation, and achieving an eightfold increase in detection speed compared with conventional […]
Read more... -
04 February 2026The C-CAMP – ICARS One Health AMR Challenge 2025 identifies seven awarded innovations for AMR across the One Health spectrum
The Centre for Cellular and Molecular Platforms (C-CAMP), with support from the International Centre for Antimicrobial Resistance Solutions (ICARS), announced the winners of the inaugural One Health AMR Challenge 2025. The initiative is part of the India AMR Innovation Hub, aligned with India’s National Action Plan 2.0 on AMR, and aims to accelerate AMR innovations […]
Read more...
More news related to Smart innovation
